Genetic risk prediction in complex disease

Human Molecular Genetics

Volumn 20, Issue R2, 2011, Pages 182-188

  Jostins, Luke ^a   Barrett, Jeffrey C ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; BRCA1 PROTEIN; BRCA2 PROTEIN;

ABDOMINAL PAIN; ACCURACY; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BREAST CANCER; CARDIOVASCULAR DISEASE; CROHN DISEASE; DIABETES MELLITUS; DIARRHEA; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; EARLY DIAGNOSIS; EFFECT SIZE; FAMILY HISTORY; FOLLOW UP; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE PERSONNEL; HUMAN; HUMAN GENOME; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; DISEASES; GENETIC PREDISPOSITION; GENETICS; REVIEW;

ANIMALS; DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RISK FACTORS;

EID: 82755175640     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr378     Document Type: Article

References (63)

1. Buijsse, B., Simmons, R.K., Griffin, S.J. and Schulze, M.B. (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol. Rev., 33, 46-62.
2. Pencina, M.J., D'Agostino, R.B., Larson, M.G., Massaro, J.M. and Vasan, R.S. (2009) Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation, 119, 3078-3084.
3. Lu, K., Kauff, N., Powell, C.B., Chen, L.M., Cass, I., Lancaster, J., Karlan, B., Berchuck, A. and Mutch, D. (2009) ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet. Gynecol., 113, 957-966.
4. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA, 106, 9362-9367.
5. Zhernakova, A., van Diemen, C.C. and Wijmenga, C. (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet., 10, 43-55.
6. Rossin, E.J., Lage, K., Raychaudhuri, S., Xavier, R.J., Tatar, D., Benita, Y., Cotsapas, C. and Daly, M.J. (2011) Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet., 7, e1001273.
7. Seliya, N., Khoshgoftaar, T.M. and Van Hulse, J. (2009) A study on the relationships of classifier performance metrics In Tools with Artificial Intelligence, 2009. ICTAI'09. 21st International Conference on, pp. 59-66. IEEE Computer Society, Washington, DC, USA. doi:10.1002/ gepi.20600.
8. Ferri, C., Hernández-Orallo, J. and Modroiu, R. (2009) An experimental comparison of performance measures for classification. Pattern Recognit. Lett., 30, 27-38.
9. Fawcett, T. (2006) An introduction to ROC analysis. Pattern Recognit. Lett., 27, 861-874.
10. Ruderfer, D.M., Korn, J. and Purcell, S.M. (2010) Family-based genetic risk prediction of multifactorial disease. Genome Med., 2, 2.
11. Clayton, D.G. (2009) Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet., 5, e1000540.
12. Newman, B., Mu, H., Butler, L.M., Millikan, R.C., Moorman, P.G. and King, M.C. (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA, 279, 915-921.
13. Anglian Breast Cancer Study Group. (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br. J. Cancer, 83, 1301-1308.
14. Risch, H.A., McLaughlin, J.R., Cole, D.E., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P.A. and Narod, S.A. (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J. Natl Cancer Inst., 98, 1694-1706.
15. Chen, S. and Parmigiani, G. (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol., 25, 1329-1333.
16. Howlader, N, Noone, A.M, Krapcho, M, Neyman, N, Aminou, R, Waldron, W, Altekruse, SF, Kosary, CL, Ruhl, J and Tatalovich, Z. (2011) SEER cancer statistics review, 1975-2008. http://seer.cancer.gov/csr/1975_2008/.
17. Barrett, J.C., Hansoul, S., Nicolae, D.L., Cho, J.H., Duerr, R.H., Rioux, J.D., Brant, S.R., Silverberg, M.S., Taylor, K.D., Barmada, M.M. et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for crohn's disease. Nat. Genet. 40, 955-962.
18. Franke, A., McGovern, D.P., Barrett, J.C., Wang, K., Radford-Smith, G.L., Ahmad, T., Lees, C.W., Balschun, T., Lee, J., Roberts, R. et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet., 42, 1118-1125.
19. Lloyd-Jones, D.M., Liu, K., Tian, L. and Greenland, P. (2006) Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann. Intern. Med., 145, 35-42.
20. Cassidy, A., Myles, J.P., van Tongeren, M., Page, R.D., Liloglou, T., Duffy, S.W. and Field, J.K. (2008) The LLP risk model: an individual risk prediction model for lung cancer. Br. J. Cancer, 98, 270-276.
21. Seddon, J.M., Reynolds, R., Maller, J., Fagerness, J.A., Daly, M.J. and Rosner, B. (2009) Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest. Ophthalmol. Vis. Sci., 50, 2044-2053.
22. Wacholder, S., Hartge, P., Prentice, R., Garcia-Closas, M., Feigelson, H.S., Diver, W.R., Thun, M.J., Cox, D.G., Hankinson, S.E., Kraft, P. et al. (2010) Performance of common genetic variants in breast-cancer risk models. N. Engl. J. Med., 362, 986-993.
23. Wray, N.R., Yang, J., Goddard, M.E. and Visscher, P.M. (2010) The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet., 6, e1000864.
24. So, H.C., Kwan, J.S., Cherny, S.S. and Sham, P.C. (2011) Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am. J. Hum. Genet., 88, 548-565.
25. Kathiresan, S., Melander, O., Anevski, D., Guiducci, C., Burtt, N.P., Roos, C., Hirschhorn, J.N., Berglund, G., Hedblad, B., Groop, L. et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med., 358, 1240-1249.
26. Companioni, O., Rodríguez Esparragón, F., Fernández-Aceituno, A.M. and Rodríguez Pérez, J.C. (2011) Genetic variants, cardiovascular risk and genome-wide association studies. Rev. Esp. Cardiol., 64, 509-514.
27. Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., McCarthy, M.I., Ramos, E.M., Cardon, L.R., Chakravarti, A. et al. (2009) Finding the missing heritability of complex diseases. Nature, 461, 747-753.
28. Lee, S.H., Wray, N.R., Goddard, M.E. and Visscher, P.M. (2011) Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet., 88, 294-305.
29. Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F. and Sklar, P. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
30. Kang, J., Kugathasan, S., Georges, M., Zhao, H. and Cho, J.H. (2011) Improved risk prediction for Crohn's disease with a multi-locus approach. Hum. Mol. Genet., 20, 2435-2442.
31. Wei, Z., Wang, K., Qu, H.Q., Zhang, H., Bradfield, J., Kim, C., Frackleton, E., Hou, C., Glessner, J.T., Chiavacci, R. et al. (2009) From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet., 5, e1000678.
32. Machiela, M.J., Chen, C.Y., Chen, C., Chanock, S.J., Hunter, D.J. and Kraft, P. (2011) Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. Genet. Epidemiol., 35, 506-514.
33. Wray, N.R. and Goddard, M.E. (2010) Multi-locus models of genetic risk of disease. Genome Med., 2, 10.
34. Lalonde, R.G., Thomas, R., Rachlis, A., Gill, M.J., Roger, M., Angel, J.B., Smith, G., Higgins, N. and Trottier, B. (2010) Successful implementation of a national HLA-B*5701 genetic testing service in Canada. Tissue Antigens, 75, 12-18.
35. Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P. and Groop, L. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med., 359, 2220-2232.
36. Wetterstrand, K.A. (2011) DNA sequencing costs: data from the NHGRI large-scale genome sequencing program. http://www.genome.gov/sequencingcosts/.
37. Worthey, E.A., Mayer, A.N., Syverson, G.D., Helbling, D., Bonacci, B.B., Decker, B., Serpe, J.M., Dasu, T., Tschannen, M.R., Veith, R.L. et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med., 13, 255-262.
38. Rios, J., Stein, E., Shendure, J., Hobbs, H.H. and Cohen, J.C. (2010) Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. Hum. Mol. Genet., 19, 4313-4318.
39. Link, D.C., Schuettpelz, L.G., Shen, D., Wang, J., Walter, M.J., Kulkarni, S., Payton, J.E., Ivanovich, J., Goodfellow, P.J., Le Beau, M. et al. (2011) Identification of a novel tp53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA, 305, 1568-1576.
40. Bell, C.J., Dinwiddie, D.L., Miller, N.A., Hateley, S.L., Ganusova, E.E., Mudge, J., Langley, R.J., Zhang, L., Lee, C.C., Schilkey, F.D. et al. (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med., 3, 65ra4.
41. Molven, A. and Njølstad, P.R. (2011) Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev. Mol. Diagn., 11, 313-320.
42. Green, R.C., Roberts, J.S., Cupples, L.A., Relkin, N.R., Whitehouse, P.J., Brown, T., Eckert, S.L., Butson, M., Sadovnick, A.D., Quaid, K.A. et al. (2009) Disclosure of APOE genotype for risk of Alzheimer's disease. N. Engl. J. Med., 361, 245-254.
43. Marteau, T.M., French, D.P., Griffin, S.J., Prevost, A.T., Sutton, S., Watkinson, C., Attwood, S. and ollands, G.J. (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst. Rev., 10, CD007275.
44. Bloss, C.S., Schork, N.J. and Topol, E.J. (2011) Effect of direct-to-consumer genomewide profiling to assess disease risk. N. Engl. J. Med., 364, 524-534.
45. International Parkinson's Disease Genomics Consortium and Wellcome Trust Case Control Consortium 2. (2011) A two-stage meta-analysis identifies several new Loci for Parkinson's disease. PLoS Genet., 7, e1002142.
46. Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.M., Saad, M., Simon-Sanchez, J., Schulte, C., Lesage, S., Sveinbjornsdottir, S. et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377, 641-649.
47. Chen, W., Stambolian, D., Edwards, A.O., Branham, K.E., Othman, M., Jakobsdottir, J., Tosakulwong, N., Pericak-Vance, M.A., Campochiaro, P.A., Klein, M.L. et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl Acad. Sci. USA, 107, 7401-7406.
48. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G. et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet., 42, 579-589.
49. Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D'Amato, M., Taylor, K.D., Lee, J.C., Goyette, P., Imielinski, M., Latiano, A. et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet., 43, 246-252.
50. Yazdanyar, S., Weischer, M. and Nordestgaard, B.G. (2009) Genotyping for NOD2 genetic variants and Crohn disease: a metaanalysis. Clin. Chem., 55, 1950-1957.
51. Stahl, E.A., Raychaudhuri, S., Remmers, E.F., Xie, G., Eyre, S., Thomson, B.P., Li, Y., Kurreeman, F.A., Zhernakova, A., Hinks, A. et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet., 42, 508-514.
52. Schunkert, H., Konig, I.R., Kathiresan, S., Reilly, M.P., Assimes, T.L., Holm, H., Preuss, M., Stewart, A.F., Barbalic, M., Gieger, C. et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet., 43, 333-338.
53. Turnbull, C., Ahmed, S., Morrison, J., Pernet, D., Renwick, A., Maranian, M., Seal, S., Ghoussaini, M., Hines, S., Healey, C.S. et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet., 42, 504-517.
54. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A. et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with alzheimer's disease. Nat. Genet., 41, 1088-1093.
55. Corneveaux, J.J., Myers, A.J., Allen, A.N., Pruzin, J.J., Ramirez, M., Engel, A., Nalls, M.A., Chen, K., Lee, W., Chewning, K. et al. (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet., 19, 3295-3301.
56. De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I., Ottoboni, L., Aggarwal, N.T., Piccio, L., Raychaudhuri, S., Tran, D., Aubin, C. et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet., 41, 776-782.
57. Shyn, S.I., Shi, J., Kraft, J.B., Potash, J.B., Knowles, J.A., Weissman, M.M., Garriock, H.A., Yokoyama, J.S., McGrath, P.J., Peters, E.J. et al. (2009) Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol. Psychiatr., 16, 202-215.
58. Scott, L.J., Muglia, P., Kong, X.Q., Guan, W., Flickinger, M., Upmanyu, R., Tozzi, F., Li, J.Z., Burmeister, M., Absher, D. et al. (2009) Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc. Natl Acad. Sci. USA, 106, 7501-7506.
59. Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Vyse, T.J., Langefeld, C.D., Nath, S.K. et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet., 40, 204-210.
60. Houlston, R.S., Webb, E., Broderick, P., Pittman, A.M., Di Bernardo, M.C., Lubbe, S., Chandler, I., Vijayakrishnan, J., Sullivan, K., Penegar, S. et al. (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet., 40, 1426-1435.
61. Eeles, R.A., Kote-Jarai, Z., Al Olama, A.A., Giles, G.G., Guy, M., Severi, G., Muir, K., Hopper, J.L., Henderson, B.E., Haiman, C.A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
62. Goode, E.L., Chenevix-Trench, G., Song, H., Ramus, S.J., Notaridou, M., Lawrenson, K., Widschwendter, M., Vierkant, R.A., Larson, M.C., Kjaer, S.K. et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet., 42, 874-879.
63. Song, H., Ramus, S.J., Tyrer, J., Bolton, K.L., Gentry-Maharaj, A., Wozniak, E., Anton-Culver, H., Chang-Claude, J., Cramer, D.W., DiCioccio, R. et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat. Genet., 41, 996-1000.